The effect of LU-AA-21004 on cardiac polarisation in male volunteers

Trial Profile

The effect of LU-AA-21004 on cardiac polarisation in male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Mar 2011

At a glance

  • Drugs Moxifloxacin; Vortioxetine
  • Indications Bacterial infections; Depressive disorders; Generalised anxiety disorder
  • Focus Adverse reactions
  • Sponsors Takeda Global Research and Development Center
  • Most Recent Events

    • 10 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top